EngMab engmab.com


EngMab is an independent biotechnology company that specializes in the research and development of T-cell bispecific antibodies (TCBs) that kill malignant cells through binding simultaneously to a tumour cell and to the T-cell receptor complex.

EngMab is an independent biotechnology company that specializes in the research and development of T-cell bispecific antibodies (TCBs) that kill malignant cells through binding simultaneously to a tumour cell and to the T-cell receptor complex.

Company (Acquired)

Phone: +41 43 433 81 28

Fax:

Etzelstrasse 27

Pfaffikon, 8808
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EngMab $0M Sep 30, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EngMab Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.